Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Middleby Corp Reports Decrease in Operating Income and EBITDA

The Middleby Corporation has reported its second quarter results for 2025, with some notable changes from the prior year. The company's operating income decreased to $155 million from $176 million in the prior year, and adjusted EBITDA also saw a decrease to $200 million from $216 million in the prior year.

The company initiated a share repurchase program and has repurchased 3.1 million of common shares through July for $448.9 million, representing 5.7% of equity. Operating cash flows for the quarter amounted to $122 million, down from $149.5 million in the prior year period.

Net sales decreased by 1.4% in the second quarter compared to the prior year, with organic net sales growth declining by 5.4%. Adjusted EBITDA for the second quarter was $200.2 million, down from $216.4 million in the prior year. The company's net debt at the end of the 2025 fiscal second quarter amounted to $1.9 billion, up from $1.7 billion at the end of fiscal 2024.

Looking ahead, the company provided expectations for the third quarter of 2025, including total revenue of $950-975 million and adjusted EBITDA of $185-195 million. For the full year 2025, the company expects total revenue of $3.81-3.87 billion, adjusted EBITDA of $770-800 million, and adjusted earnings per share of $8.65-9.05.

The company's CEO, Tim Fitzgerald, expressed confidence in Middleby's trajectory and highlighted the allocation of free cash flow toward share repurchases, indicating a belief that the current market valuation does not reflect the substantial growth opportunities ahead.

The market has reacted to these announcements by moving the company's shares 2.04% to a price of $144.71. For the full picture, make sure to review MIDDLEBY Corp's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS